Home > UK

UK MHRA Approves Beyfortus to Prevent RSV in newborns

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Beyfortus (nirsevimab) to treat respiratory syncytial virus (RSV) lower respiratory tract disease in the infants and newborns during their first RSV season. This approval come after the European Commission approve Beyfortus earlier this month. According to studies, about 90 percent

Read More

Oncopeptides Pepaxti gets Marketing Authorization by MHRA in UK

Oncopeptides AB, a biotech company focused on R&D of development of therapies to treat haematological diseases, announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization for Pepaxti in combination with dexamethasone in the United Kingdom. The approval of Pepaxti in the United Kingdom is an

Read More